ProShare Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $26.3K | Sell |
|
|||||
|
2024
Q4 | $46.8K | Buy |
|
|||||
|
2024
Q3 | $43.9K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $7.4K | Buy |
|
|||||
|
2023
Q2 | $7.04K | Sell |
|
|||||
|
2023
Q1 | $27.8K | Sell |
|
|||||
|
2022
Q4 | $100K | Buy |
|
|||||
|
2022
Q3 | $130K | Sell |
|
|||||
|
2022
Q2 | $165K | Buy |
|
|||||
|
2022
Q1 | $161K | Sell |
|
|||||
|
2021
Q4 | $492K | Sell |
|
|||||
|
2021
Q3 | $1.01M | Buy |
|
|||||
|
2021
Q2 | $911K | Buy |
|
|||||
|
2021
Q1 | $853K | Sell |
|
|||||
|
2020
Q4 | $764K | Buy |
|
|||||
|
2020
Q3 | $730K | Buy |
|
|||||
|
2020
Q2 | $998K | Buy |
|
|||||
|
2020
Q1 | $605K | Sell |
|
|||||
|
2019
Q4 | $1.23M | Sell |
|
|||||
|
2019
Q3 | $1.31M | Sell |
|
|||||
|
2019
Q2 | $2.62M | Sell |
|
|||||
|
2019
Q1 | $3.26M | Sell |
|
|||||
|
2018
Q4 | $4.88M | Buy |
|
|||||
|
2018
Q3 | $8.5M | Buy |
|
|||||
|
2018
Q2 | $5.54M | Sell |
|
|||||
|
2018
Q1 | $12.6M | Buy |
|
|||||
|
2017
Q4 | $6.92M | Buy |
|
|||||
|
2017
Q3 | $2.52M | Buy |
|
|||||
|
2017
Q2 | $1.86M | Sell |
|
|||||
|
2017
Q1 | $2.38M | Sell |
|
|||||
|
2016
Q4 | $1.56M | Buy |
|
|||||
|
2016
Q3 | $1.78M | Sell |
|
|||||
|
2016
Q2 | $1.71M | Buy |
|
|||||
|
2016
Q1 | $1.62M | Sell |
|
|||||
|
2015
Q4 | $2.19M | Buy |
|
|||||
|
2015
Q3 | $1.27M | Sell |
|
|||||
|
2015
Q2 | $1.55M | Sell |
|
|||||
|
2015
Q1 | $1.43M | Buy |
|
|||||
|
2014
Q4 | $1.74M | Sell |
|
|||||
|
2014
Q3 | $1.4M | Sell |
|
|||||
|
2014
Q2 | $1.84M | Sell |
|
|||||
|
2014
Q1 | $2.76M | Buy |
|
|||||
|
2013
Q4 | $719K | Sell |
|
|||||
|
2013
Q3 | $1.22M | Buy |
|
|||||
|
2013
Q2 | $1.15M | Buy |
|